Sector

Articles

Piramal opens oral solid dosage suite in Pennsylvania for NewAmsterdam

The Sellersville site expansion will support production of NewAmsterdam Pharma’s investigational fixed-dose combination cholesterol therapy.

WuXi Biologics reports 2025 growth with expanded services, new capacity

The Chinese CRDMO attributed the results in the first half of 2025 to operational efficiency gains, technology platform expansion, and facility ramp-ups in Europe.

Upperton Pharma Solutions, Oxford University partner to advance oral vaccine formulation

The UK-based CDMO will contribute formulation expertise to a project aimed at addressing the limitations of intramuscular vaccine administration.

American Injectables expands its FDA-approved sterile fill-finish facility

The expansion adds aseptic lines for syringes and vials, formulation and R&D capacity, and commercial-scale packaging capabilities at its Brooksville, Florida site.

Oxford Biomedica expands US capacity to meet viral vector demand

The $78 million investment will support large-scale GMP production, fill-finish, and advanced automation.

News

ProBio launches cGMP AAV manufacturing at New Jersey facility

Made Scientific opens GMP cell therapy facility in New Jersey

WuXi Biologics achieves pilot-scale automated continuous drug substance production

Bionova opens Texas pDNA facility to expand cell and gene therapy support

WuXi Biologics launches stable cell line platform for development, manufacturing

Sumitomo’s CDMO to double regenerative medicine manufacturing capacity

WuXi XDC boosts sterile drug product capacity with new China facility

The Chinese CRDMO’s newest GMP-compliant facility in Wuxi adds seven million vials of annual capacity, expanding its bioconjugate drug product network.

Bora expands Minnesota site with roller compactor and new OSD capacity

The Taiwan-based pharmaceutical CDMO is investing in facility upgrades following its $210 million acquisition of Upsher-Smith Laboratories.

Axplora expands India API capacity with €6.5M investment following FDA inspections

The CDMO’s Vizag site upgrade will help meet growing global demand for active pharmaceutical ingredients, according to the announcement.

Esteve expands CDMO footprint with Regis Technologies acquisition

The deal marks Barcelona-based Esteve’s entry into the U.S. market for small-molecule API development and manufacturing.

ViroCell collaborates with AvenCell to support investigational cell therapy

The CDMO’s retroviral vector will be used to manufacture AvenCell’s investigational dual-targeted therapy for B cell malignancies and autoimmune diseases.